2025-520946-31-00Not yet recruitingPhase 1
Phase I clinical trial evaluating TG4070 in patients with non-small cell lung cancer
Source: EU CTIS (euclinicaltrials.eu) · Last updated 3 Nov 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 5 Mar 2025
- Start date
- 1 Dec 2025
- Lead sponsor
- Transgene
- Diseases
- Lung cancer
- EU CT number
- 2025-520946-31-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 40
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (5)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Regional De Marseille | Marseille | France | Not yet recruiting |
| Institut Curie | Paris | France | Not yet recruiting |
| Centre Hospitalier Universitaire De Rennes | Rennes Cedex 9 | France | Not yet recruiting |
| Les Hopitaux Universitaires De Strasbourg | Strasbourg Cedex | France | Not yet recruiting |
| Oncopole Claudius Regaud | Toulouse Cedex 9 | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.